Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1
Neurofibromatosis 1 has various complications. To elucidate the frequency of neurofibromatosis 1-related major complications requiring medical intervention, a nationwide retrospective study was conducted of 3,530 patients with neurofibromatosis 1 registered from 2001 to 2014 in Japan. The ratio of c...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society for Publication of Acta Dermato-Venereologica
2018-06-01
|
Series: | Acta Dermato-Venereologica |
Subjects: | |
Online Access: |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2975
|
id |
doaj-c996969e7e8a44b2914d7c690c9c6041 |
---|---|
record_format |
Article |
spelling |
doaj-c996969e7e8a44b2914d7c690c9c60412020-11-24T21:32:23ZengSociety for Publication of Acta Dermato-VenereologicaActa Dermato-Venereologica0001-55551651-20572018-06-0198875375610.2340/00015555-29755246Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1Yuichi Yoshida0Yuko EharaMonji KogaShinichi ImafukuOsamu Yamamoto Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, 86 Nishi-cho, Yonago-shi, Tottori 683-8503, Japan. yxyhifu1@med.tottori-u.ac.jp, yxy0630@gmail.com. Neurofibromatosis 1 has various complications. To elucidate the frequency of neurofibromatosis 1-related major complications requiring medical intervention, a nationwide retrospective study was conducted of 3,530 patients with neurofibromatosis 1 registered from 2001 to 2014 in Japan. The ratio of certified patients requiring medical intervention (>stage 3) was 82%. Patients classified in the most severe grade experienced dermatological complications (71.8% of patients), neurological complications (38.1%) and bone complications (33.3%). In patients with dermatological manifestations, medical treatment was needed for cutaneous neurofibromas (58%), diffuse plexiform neurofibromas (31%) and malignant peripheral nerve sheath tumours (10%). Patients with neurological manifestations needed medical treatment mainly for brain tumours (53%) and intellectual disability (26%). Patients with bone manifestations needed medical treatment for pseudoarthrosis (9%), scoliosis (55%) and bone defects (16%). It is necessary for physicians to be aware of neurofibromatosis 1-related complications requiring medical intervention in order to provide appropriate care for patients with neurofibromatosis 1. https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2975 neurofibromatosis1epidemiologytreatmentsurvey |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yuichi Yoshida Yuko Ehara Monji Koga Shinichi Imafuku Osamu Yamamoto |
spellingShingle |
Yuichi Yoshida Yuko Ehara Monji Koga Shinichi Imafuku Osamu Yamamoto Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 Acta Dermato-Venereologica neurofibromatosis1 epidemiology treatment survey |
author_facet |
Yuichi Yoshida Yuko Ehara Monji Koga Shinichi Imafuku Osamu Yamamoto |
author_sort |
Yuichi Yoshida |
title |
Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 |
title_short |
Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 |
title_full |
Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 |
title_fullStr |
Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 |
title_full_unstemmed |
Epidemiological Analysis of Major Complications Requiring Medical Intervention in Patients with Neurofibromatosis 1 |
title_sort |
epidemiological analysis of major complications requiring medical intervention in patients with neurofibromatosis 1 |
publisher |
Society for Publication of Acta Dermato-Venereologica |
series |
Acta Dermato-Venereologica |
issn |
0001-5555 1651-2057 |
publishDate |
2018-06-01 |
description |
Neurofibromatosis 1 has various complications. To elucidate the frequency of neurofibromatosis 1-related major complications requiring medical intervention, a nationwide retrospective study was conducted of 3,530 patients with neurofibromatosis 1 registered from 2001 to 2014 in Japan. The ratio of certified patients requiring medical intervention (>stage 3) was 82%. Patients classified in the most severe grade experienced dermatological complications (71.8% of patients), neurological complications (38.1%) and bone complications (33.3%). In patients with dermatological manifestations, medical treatment was needed for cutaneous neurofibromas (58%), diffuse plexiform neurofibromas (31%) and malignant peripheral nerve sheath tumours (10%). Patients with neurological manifestations needed medical treatment mainly for brain tumours (53%) and intellectual disability (26%). Patients with bone manifestations needed medical treatment for pseudoarthrosis (9%), scoliosis (55%) and bone defects (16%). It is necessary for physicians to be aware of neurofibromatosis 1-related complications requiring medical intervention in order to provide appropriate care for patients with neurofibromatosis 1. |
topic |
neurofibromatosis1 epidemiology treatment survey |
url |
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-2975
|
work_keys_str_mv |
AT yuichiyoshida epidemiologicalanalysisofmajorcomplicationsrequiringmedicalinterventioninpatientswithneurofibromatosis1 AT yukoehara epidemiologicalanalysisofmajorcomplicationsrequiringmedicalinterventioninpatientswithneurofibromatosis1 AT monjikoga epidemiologicalanalysisofmajorcomplicationsrequiringmedicalinterventioninpatientswithneurofibromatosis1 AT shinichiimafuku epidemiologicalanalysisofmajorcomplicationsrequiringmedicalinterventioninpatientswithneurofibromatosis1 AT osamuyamamoto epidemiologicalanalysisofmajorcomplicationsrequiringmedicalinterventioninpatientswithneurofibromatosis1 |
_version_ |
1725957774096990208 |